Abstract: The invention pertains to a method for reducing proliferation or viability of melanoma cells by contacting the cells with nanoclay. It also involves pharmaceutical composition containing nanoclay for treatment of melanoma.

Abstract: The invention pertains to a method for reducing proliferation or viability of melanoma cells by contacting the cells with nanoclay. It also involves pharmaceutical composition containing nanoclay for treatment of melanoma.

Abstract: A method of reducing the swell potential of an expansive clayey soil comprising expansive clay mineral(s) at a proportion of the total weight of the expansive clayey soil (PECM). The method includes (a) calculating a first amount of a swelling reduction agent to be incorporated into the expansive clayey soil to form a first swelling reduction agent incorporated expansive clayey soil with a reduced swell potential no greater than a pre-set level T with a nano-level constitutive modeling based on the water content and the CEC of the expansive clayey soil and PECM. The swelling reduction agent is at least one selected from calcite, gypsum, potassium chloride, a composition comprising exchangeable K+, a composition comprising exchangeable Ca2+, and/or a composition comprising exchangeable Mg2+, and (b) incorporating the first amount of the swelling reduction agent into the expansive clayey soil to form the first swelling reduction agent incorporated expansive clayey soil.

Abstract: A method for enhancing or restoring adhesion to cells that have partially or completely loss the ability to adhere to a substrate or other cells using nanosized clay crystallites.

Abstract: A method of reducing the swell potential of an expansive clay mineral. The method includes (a) carrying out a forcefield-modified molecular level simulation to determine an amount of a swelling reduction agent to be incorporated into the expansive clay mineral to form a swelling reduction agent incorporated expansive clay mineral with a reduced swell potential Si(ECM) that is no greater than a pre-set level T, wherein the swelling reduction agent comprises at least one cementation material of calcite, gypsum, and potassium chloride and/or at least one exchangeable cation of K+, Ca2+, and Mg2+, and wherein the forcefield-modified molecular level simulation comprises molecular mechanics, molecular dynamics, and Monte Carlo simulation techniques configured to simulate the reduced swell potential Si(ECM), and (b) incorporating the amount of the swelling reduction agent into the expansive clay mineral to form the swelling reduction agent incorporated expansive clay mineral.

Abstract: A method of reducing the swell potential of an expansive clay mineral. The method includes (a) carrying out a forcefield-modified molecular level simulation to determine an amount of a swelling reduction agent to be incorporated into the expansive clay mineral to form a swelling reduction agent incorporated expansive clay mineral with a reduced swell potential Si(ECM) that is no greater than a pre-set level T, wherein the swelling reduction agent comprises at least one cementation material of calcite, gypsum, and potassium chloride and/or at least one exchangeable cation of K+, Ca2+, and Mg2+, and wherein the forcefield-modified molecular level simulation comprises molecular mechanics, molecular dynamics, and Monte Carlo simulation techniques configured to simulate the reduced swell potential Si(ECM), and (b) incorporating the amount of the swelling reduction agent into the expansive clay mineral to form the swelling reduction agent incorporated expansive clay mineral.

Abstract: A method of reducing the swell potential of an expansive clay mineral. The method includes (a) carrying out a forcefield-modified molecular level simulation to determine an amount of a swelling reduction agent to be incorporated into the expansive clay mineral to form a swelling reduction agent incorporated expansive clay mineral with a reduced swell potential Si(ECM) that is no greater than a pre-set level T, wherein the swelling reduction agent comprises at least one cementation material of calcite, gypsum, and potassium chloride and/or at least one exchangeable cation of K+, Ca2+, and Mg2+, and wherein the forcefield-modified molecular level simulation comprises molecular mechanics, molecular dynamics, and Monte Carlo simulation techniques configured to simulate the reduced swell potential Si(ECM), and (b) incorporating the amount of the swelling reduction agent into the expansive clay mineral to form the swelling reduction agent incorporated expansive clay mineral.

Abstract: A method of reducing the swell potential of an expansive clay mineral. The method includes (a) carrying out a forcefield-modified molecular level simulation to determine an amount of a swelling reduction agent to be incorporated into the expansive clay mineral to form a swelling reduction agent incorporated expansive clay mineral with a reduced swell potential Si(ECM) that is no greater than a pre-set level T, wherein the swelling reduction agent comprises at least one cementation material of calcite, gypsum, and potassium chloride and/or at least one exchangeable cation of K+, Ca2+, and Mg2+, and wherein the forcefield-modified molecular level simulation comprises molecular mechanics, molecular dynamics, and Monte Carlo simulation techniques configured to simulate the reduced swell potential Si(ECM), and (b) incorporating the amount of the swelling reduction agent into the expansive clay mineral to form the swelling reduction agent incorporated expansive clay mineral.

Abstract: A method of reducing the swell potential of an expansive clay mineral. The method includes (a) carrying out a forcefield-modified molecular level simulation to determine an amount of a swelling reduction agent to be incorporated into the expansive clay mineral to form a swelling reduction agent incorporated expansive clay mineral with a reduced swell potential Si(ECM) that is no greater than a pre-set level T, wherein the swelling reduction agent comprises at least one cementation material of calcite, gypsum, and potassium chloride and/or at least one exchangeable cation of K+, Ca2+, and Mg2+, and wherein the forcefield-modified molecular level simulation comprises molecular mechanics, molecular dynamics, and Monte Carlo simulation techniques configured to simulate the reduced swell potential Si(ECM), and (b) incorporating the amount of the swelling reduction agent into the expansive clay mineral to form the swelling reduction agent incorporated expansive clay mineral.

Abstract: A method of reducing the swell potential of an expansive clayey soil comprising expansive clay mineral(s) at a proportion of the total weight of the expansive clayey soil (PECM). The method includes (a) calculating a first amount of a swelling reduction agent to be incorporated into the expansive clayey soil to form a first swelling reduction agent incorporated expansive clayey soil with a reduced swell potential no greater than a pre-set level T with a nano-level constitutive modeling based on the water content and the CEC of the expansive clayey soil and PECM. The swelling reduction agent is at least one selected from calcite, gypsum, potassium chloride, a composition comprising exchangeable K+, a composition comprising exchangeable Ca2+, and/or a composition comprising exchangeable Mg2+, and (b) incorporating the first amount of the swelling reduction agent into the expansive clayey soil to form the first swelling reduction agent incorporated expansive clayey soil.

Abstract: A method of reducing the swell potential of an expansive clayey soil comprising expansive clay mineral(s) at a proportion of the total weight of the expansive clayey soil (PECM). The method includes (a) calculating a first amount of a swelling reduction agent to be incorporated into the expansive clayey soil to form a first swelling reduction agent incorporated expansive clayey soil with a reduced swell potential no greater than a pre-set level T with a nano-level constitutive modeling based on the water content and the CEC of the expansive clayey soil and PECM. The swelling reduction agent is at least one selected from calcite, gypsum, potassium chloride, a composition comprising exchangeable K+, a composition comprising exchangeable Ca2+, and/or a composition comprising exchangeable Mg2+, and (b) incorporating the first amount of the swelling reduction agent into the expansive clayey soil to form the first swelling reduction agent incorporated expansive clayey soil.

Abstract: A method of reducing the swell potential of an expansive clay mineral. The method includes (a) carrying out a forcefield-modified molecular level simulation to determine an amount of a swelling reduction agent to be incorporated into the expansive clay mineral to form a swelling reduction agent incorporated expansive clay mineral with a reduced swell potential Si(ECM) that is no greater than a pre-set level T, wherein the swelling reduction agent comprises at least one cementation material of calcite, gypsum, and potassium chloride and/or at least one exchangeable cation of K+, Ca2+, and Mg2+, and wherein the forcefield-modified molecular level simulation comprises molecular mechanics, molecular dynamics, and Monte Carlo simulation techniques configured to simulate the reduced swell potential Si(ECM), and (b) incorporating the amount of the swelling reduction agent into the expansive clay mineral to form the swelling reduction agent incorporated expansive clay mineral.

Abstract: A method of reducing the swell potential of an expansive clay mineral. The method includes (a) carrying out a forcefield-modified molecular level simulation to determine an amount of a swelling reduction agent to be incorporated into the expansive clay mineral to form a swelling reduction agent incorporated expansive clay mineral with a reduced swell potential Si(ECM) that is no greater than a pre-set level T, wherein the swelling reduction agent comprises at least one cementation material of calcite, gypsum, and potassium chloride and/or at least one exchangeable cation of K+, Ca2+, and Mg2+, and wherein the forcefield-modified molecular level simulation comprises molecular mechanics, molecular dynamics, and Monte Carlo simulation techniques configured to simulate the reduced swell potential Si(ECM), and (b) incorporating the amount of the swelling reduction agent into the expansive clay mineral to form the swelling reduction agent incorporated expansive clay mineral.

Abstract: A method of reducing the swell potential of an expansive clayey soil comprising expansive clay mineral(s) at a proportion of the total weight of the expansive clayey soil (PECM). The method includes (a) calculating a first amount of a swelling reduction agent to be incorporated into the expansive clayey soil to form a first swelling reduction agent incorporated expansive clayey soil with a reduced swell potential no greater than a pre-set level T with a nano-level constitutive modeling based on the water content and the CEC of the expansive clayey soil and PECM. The swelling reduction agent is at least one selected from calcite, gypsum, potassium chloride, a composition comprising exchangeable K+, a composition comprising exchangeable Ca2+, and/or a composition comprising exchangeable Mg2+, and (b) incorporating the first amount of the swelling reduction agent into the expansive clayey soil to form the first swelling reduction agent incorporated expansive clayey soil.

Abstract: A method of reducing the swell potential of an expansive clayey soil comprising expansive clay mineral(s) at a proportion of the total weight of the expansive clayey soil (PECM). The method includes (a) calculating a first amount of a swelling reduction agent to be incorporated into the expansive clayey soil to form a first swelling reduction agent incorporated expansive clayey soil with a reduced swell potential no greater than a pre-set level T with a nano-level constitutive modeling based on the water content and the CEC of the expansive clayey soil and PECM. The swelling reduction agent is at least one selected from calcite, gypsum, potassium chloride, a composition comprising exchangeable K+, a composition comprising exchangeable Ca2, and/or a composition comprising exchangeable Mg2+, and (b) incorporating the first amount of the swelling reduction agent into the expansive clayey soil to form the first swelling reduction agent incorporated expansive clayey soil.

Abstract: A method of reducing the swell potential of an expansive clay mineral. The method includes (a) carrying out a forcefield-modified molecular level simulation to determine an amount of a swelling reduction agent to be incorporated into the expansive clay mineral to form a swelling reduction agent incorporated expansive clay mineral with a reduced swell potential Si(ECM) that is no greater than a pre-set level T, wherein the swelling reduction agent comprises at least one cementation material of calcite, gypsum, and potassium chloride and/or at least one exchangeable cation of K+, Ca2+, and Mg2+, and wherein the forcefield-modified molecular level simulation comprises molecular mechanics, molecular dynamics, and Monte Carlo simulation techniques configured to simulate the reduced swell potential Si(ECM), and (b) incorporating the amount of the swelling reduction agent into the expansive clay mineral to form the swelling reduction agent incorporated expansive clay mineral.

Abstract: A method of reducing the swell potential of an expansive clayey soil comprising expansive clay mineral(s) at a proportion of the total weight of the expansive clayey soil (PECM). The method includes (a) calculating a first amount of a swelling reduction agent to be incorporated into the expansive clayey soil to form a first swelling reduction agent incorporated expansive clayey soil with a reduced swell potential no greater than a pre-set level T with a nano-level constitutive modeling based on the water content and the CEC of the expansive clayey soil and PECM. The swelling reduction agent is at least one selected from calcite, gypsum, potassium chloride, a composition comprising exchangeable K+, a composition comprising exchangeable Ca2?, and/or a composition comprising exchangeable Mg2+, and (b) incorporating the first amount of the swelling reduction agent into the expansive clayey soil to form the first swelling reduction agent incorporated expansive clayey soil.